Mon, 30 Nov 2020 13:39:42: Cambridge, Lund University spinout Wren pens Eisai neuro research pact

Mon, 30 Nov 2020 12:26:43: Moderna sketches out 94.1% efficacy for COVID-19 vax based on more cases, with EUA plotted for today

Mon, 30 Nov 2020 12:22:24: Enhancing cancer-fighting T cells by manipulating their microenvironment

Mon, 30 Nov 2020 10:33:51: Biogen bets $1.5B on Sage's once-failed depression drug

Mon, 30 Nov 2020 09:48:32: AstraZeneca nears temporary OK for COVID-19 vaccine, plots extra trial

Wed, 25 Nov 2020 13:32:39: Fancy a Black Friday R&D deal? Astellas has you covered

Wed, 25 Nov 2020 12:43:04: Cancer-killing virus escapes immune destruction and fights metastatic lung tumors in mice

Wed, 25 Nov 2020 11:47:09: BioNTech, Fosun start COVID-19 vaccine trial to support Chinese approval

Wed, 25 Nov 2020 11:01:15: Urovant's vibegron flunks irritable bowel syndrome phase 2

Wed, 25 Nov 2020 09:01:06: Galapagos sells off Fidelta as CRO activities 'no longer fit with its strategy'

Tue, 24 Nov 2020 14:48:17: Anti-aging biotech Elevian raises $15M as it looks to the clinic

Tue, 24 Nov 2020 13:37:22: Hoping for an endgame, GSK kick-starts phase 3 RSV vaccine trial in pregnant women

Tue, 24 Nov 2020 13:11:43: AstraZeneca probes 'mistake' behind 90% COVID-19 vaccine efficacy

Tue, 24 Nov 2020 11:56:56: Twist Bioscience's COVID-19 'nanobodies,' inspired by llamas, show promise in hamsters

Tue, 24 Nov 2020 11:37:22: Immunocore's TCR bispecific improves survival in solid tumor phase 3

Mon, 23 Nov 2020 13:20:06: Merck inks $425M OncoImmune buyout to bag COVID-19 drug

Mon, 23 Nov 2020 13:15:38: Black Diamond's EFGR-targeted glioblastoma drug candidate slows tumor growth in mice

Mon, 23 Nov 2020 10:58:51: AstraZeneca's COVID-19 vaccine 70% effective, shares fall

Mon, 23 Nov 2020 08:55:48: Belgium biotech argenx nabs Bayer speedy review voucher for a cool $98M

Fri, 20 Nov 2020 13:27:03: Adagio's COVID-19 antibody protects mice and zaps related viruses in lab tests

Fri, 20 Nov 2020 13:19:15: ADC gets priority review for anti-CD19 blood cancer drug

Fri, 20 Nov 2020 11:47:11: Novartis licenses phase 3 COVID-19 cell therapy from Mesoblast

Fri, 20 Nov 2020 08:56:54: Ahead of possible Japanese approval, Metavant backs away from Poxel-partnered imeglimin

Thu, 19 Nov 2020 21:39:11: Chutes & Ladders—Longtime AbbVie commercial chief Alban announces retirement

Thu, 19 Nov 2020 15:38:25: Gene therapy hemophilia B 'cure' approach heats up as uniQure/CSL, rivaling Pfizer, shows promise